Skip to main content
SpringerLink
Log in

Osteopenia and Osteoporosis

  • Chapter
  • First Online:
Ambulatory Gynecology

  • 711 Accesses

Abstract

Osteoporosis is a term that means “porous bones.” It is a skeletal disease affecting both women and men. Osteoporosis is a condition in which bones have lost minerals especially calcium, making them weaker, more brittle, and susceptible to fractures. Any bone in the body can be affected by osteoporosis, but the most common places where fractures occur are the back (spine), hips, and wrists.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Cooper C, Atkinson EJ, Jacobsen SJ, et al. Population-based study of survival after osteoporotic fractures. Am J Epidemiol. 1993;137:1001.

    Article  CAS  Google Scholar 

  2. Leibson CL, Tosteson AN, Gabriel SE, et al. Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc. 2002;50:1644.

    Article  Google Scholar 

  3. Magaziner J, Lydick E, Hawkes W, et al. Excess mortality attributable to hip fracture in white women aged 70 years and older. Am J Public Health. 1997;87:1630.

    Article  CAS  Google Scholar 

  4. Magaziner J, Simonsick EM, Kashner TM, et al. Predictors of functional recovery one year following hospital discharge for hip fracture: a prospective study. J Gerontol. 1990:45. MlOl

    Google Scholar 

  5. Riggs BL, Melton LJ 3rd. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone. 1995;17:505S.

    Article  CAS  Google Scholar 

  6. Kannus P, Parkkari J, Niemi S, Palvanen M. Epidemiology of osteoporotic ankle fractures in elderly persons in Finland. Ann Intern Med. 1996;25:975.

    Article  Google Scholar 

  7. US Department of Health and Human Services. Bone health and osteoporosis: a report of the surgeon general. Rockville: US Department of Health and Human Services, Office of the Surgeon General; 2004.

    Google Scholar 

  8. Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137–41.

    Article  CAS  Google Scholar 

  9. Nieves JW, Cosman F. Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates. Curr Osteoporos Rep. 2010;8:34–9.

    Article  Google Scholar 

  10. Green J, Czanner G, Reeves G, Watson J, Wise L, Beral V. Oral bisphosphonates and risk of cancer of the oesophagus, stomach and colorectum: case-control analysis within a UK primary case cohort. BMJ. 2010;341:c4444.

    Article  Google Scholar 

  11. Ensrud KE, Ewing SK, Stone KL, Cauley JA, Bowman PJ, Cummings SR. For the study of osteoporotic fractures research group. Intentional and unintentional weight loss increases bone loss and hip fracture risk in older women. J Am Geriatr Soc. 2003;51:1740–7.

    Article  Google Scholar 

  12. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010. https://doi.org/10.1136/bmj.c3691.

  13. Prince RL, Devine A, Dhaliwal SS, Dick IM. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med. 2006;166:869–75.

    Article  CAS  Google Scholar 

  14. Dawson-Hughes B, Dallal GE, Krall EA, et al. A controlled trial of the effects of calcium supplementation on bone density in postmenopausal women. N Engl J Med. 1990;23:878–83.

    Article  Google Scholar 

  15. Sahni S, Hannan MT, Gagnon D, Blumberg J, Cupples LA, Kiel DP, Tucker KL. Protective effect of total and supplemental vitamin C intake on the risk of hip fracture-a 17-year follow-up from the Framingham osteoporosis study. Osteoporos Int. 2009;20:1853–61.

    Article  CAS  Google Scholar 

  16. Lunt M, Masaryk P, Scheidt-Nave C, et al. The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS study. Osteoporos Int. 2001;12:688–98.

    Article  CAS  Google Scholar 

  17. Wilsgaard T, Emaus N, Ahmed LA, et al. Lifestyle impact on lifetime bone loss in women and men: the Tromso study. Am J Epidemiol. 2009;169:877–86.

    Article  Google Scholar 

  18. Dook JE, James C, Henderson NK, Price RI. Exercise and bone mineral density in mature female athletes. Med Sci Sports Exerc. 1997;29:291–6.

    Article  CAS  Google Scholar 

  19. Verschueren SM, Roelants M, Delecluse C, Swinnen S, Vanderscheren D, Boonen S. Effect of 6-month whole body vibration training on hip density, muscle strength, and postural control in post-menopausal women: a randomized controlled pilot study. J Bone Miner Res. 2004;19:343–51.

    Article  Google Scholar 

  20. Robertson MC, Campbell AJ, Gardner MM, Devlin N. Preventing injuries in older people by preventing falls: a meta-analysis of individual-level data. J Am Geriatr Soc. 2002;50:905–11.

    Article  Google Scholar 

  21. Krall EA, Dawson-Huges B. Smoking and bone loss among post-menopausal women. J Bone Miner Res. 1991;6:331–8.

    Article  CAS  Google Scholar 

  22. Baron JA, Johnell O, Oden A, et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int. 2005;16:155–62.

    Article  Google Scholar 

  23. Tosteson ANA, Grove MR, Hammond CS, et al. Early discontinuation of treatment for osteoporosis. Am J Med. 2003;115:209–16.

    Article  Google Scholar 

  24. McClung M. Bisphosphonates. Endocrinol Metab Clin N Am. 2003;32:253–71.

    Article  CAS  Google Scholar 

  25. Black DM, Cummings SR, David B, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet. 1996;348:1535–41. [FITI trial]

    Article  CAS  Google Scholar 

  26. Cummings SR, MD, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the fracture intervention trial. JAMA. 1998;280:2077–2082. [FIT2 trial].

    Google Scholar 

  27. Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and non-vertebral fractures in women with post-menopausal osteoporosis: a randomized controlled trial. JAMA. 1999;282:1344–52.

    Article  CAS  Google Scholar 

  28. Reginster J, Minne HW, Sorenson OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) study group. Osteoporos Int. 2000;11:83–91.

    Article  CAS  Google Scholar 

  29. Reginster JY, Adami S, Lakatos P, et al. Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study. Ann Rheum Dis. 2006;65(5):654–61. [MOBILE trial]

    Article  CAS  Google Scholar 

  30. Delmas PD, Adami S, Strugala C, et al. Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study. Arthritis Rheum. 2006;54(6):1838–46. [DIVA trial]

    Article  CAS  Google Scholar 

  31. Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. NEJM. 2007;356(18):1809–22. [HORIZON Pivotal Fracture trial]

    Article  CAS  Google Scholar 

  32. Lyles KW, Colon-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007;357:1799–809. [HORIZON Recurrent Fracture trial]

    Article  CAS  Google Scholar 

  33. Neer R, Arnaud C, Zanchetta JR, et al. Recombinant human PTH [rhPTH(l-34)] reduces the risk of spine and non-spine fractures in postmenopausal osteoporosis. NEJM. 2001;344:1434–41. [Fracture Prevential trial]

    Article  CAS  Google Scholar 

  34. Lindsay R, Scheele WH, Neer R, et al. Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis. Arch Intern Med. 2004;164:2024–30. [Fracture Prevential trial follow-up]

    Article  Google Scholar 

  35. Gallagher JC, Genant HK, Crans GG, Vargas SJ, Krege JH. Teriparatide reduces the fracture risk associated with increasing number and severity of osteoporotic fractures. J Clin Endocrinol Metab. 2005;90:1583–7.

    Article  CAS  Google Scholar 

  36. Ettinger B, Black DM, Bruce H, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA. 1999;282:637–45. [MORE trial]

    Article  CAS  Google Scholar 

  37. Cummings SR, Eckert S, Krueger KA, et al. The effect of raloxifene on risk of breat cancer in postmenopausal women: results from the MORE randomized trial. Multiple outcomes of raloxifene evaluation. JAMA. 1999;281:2189–97.

    Article  CAS  Google Scholar 

  38. Cummings SR, Martin JS, McClung MR, et al. For the FREEDOM trial. Denosumab for the prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361:756–65.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Saint Francis Hospital Evanston, Evanston, IL, USA

    Sharon Beth Rosenberg MD

Authors
  1. Sharon Beth Rosenberg MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Gynecologic Oncology, Presence Saint Francis Hospital, Evanston, Illinois, USA

    John V. Knaus

  2. Presence Saint Francis Hospital, Department of Medical Education, Evanston, Illinois, USA

    Marko J. Jachtorowycz

  3. Medical Education, St. Francis Hospital, Evanston, Illinois, USA

    Allan A. Adajar

  4. Presence Saint Francis Hospital, Department of Obstetrics and Gynecology, Evanston, Illinois, USA

    Teresa Tam

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media, LLC, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rosenberg, S.B. (2018). Osteopenia and Osteoporosis. In: Knaus, J., Jachtorowycz, M., Adajar, A., Tam, T. (eds) Ambulatory Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-7641-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7641-6_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-7639-3

  • Online ISBN: 978-1-4939-7641-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation